Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer

Part of paid clinical trials in San Antonio, Texas.

Sponsor
The University of Texas Health Science Center at San Antonio
Study ID
NCT03655015
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Lung Tumor Resection — PROCEDURE
    Lung Tumor Resection

Study Details

Create a living biobank of PDOs from Stage I-III lung cancer patients.

Key Dates

Start date
Oct 16, 2018
Status verified
Apr 2026
Primary completion
Dec 1, 2028
Completion
Dec 1, 2029

Study Design

Enrollment
150 participants (estimated)

Primary Outcome Measure

To establish and characterize a biobank of patient-derived organoids (PDOs), and investigate the potential of PDOs to recapitulate ex vivo responses to chemotherapeutic and targeted agents observed in the clinic. [ Time Frame: 10 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
UT Health San Antonio, M.D. Anderson Cancer CenterSan AntonioTexas78229
Research Office
[email protected]
210-450-1000
Josephine Taverna, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in San Antonio, TX

By condition
Lung cancer
By specialty
OncologyLung oncologyLung disease
By research site
UT Health San Antonio, M.D. Anderson Cancer Center· San Antonio, TX

Related Studies